BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 154519)

  • 1. A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.
    Paoni NF; Castellino FJ
    J Biol Chem; 1979 Mar; 254(6):2064-70. PubMed ID: 154519
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation mechanism of human plasminogen.
    Rickli EE
    Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
    [No Abstract]   [Full Text] [Related]  

  • 3. The activation of two isozymes of glu-plasminogen (I and II) by urokinase and streptokinase.
    Takada A; Takada Y
    Thromb Res; 1983 Jun; 30(6):633-42. PubMed ID: 6351345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of urokinase-induced plasminogen activation by the cationic protein of human eosinophil granulocytes.
    Dahl R; Venge P
    Thromb Res; 1979; 14(4-5):599-608. PubMed ID: 483258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular mechanisms of thrombolytic therapy].
    Lijnen HR; Collen D
    Haemostasis; 1986; 16 Suppl 4():3-15. PubMed ID: 2945768
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442.
    Powell JR; Castellino FJ
    J Biol Chem; 1980 Jun; 255(11):5329-35. PubMed ID: 6445361
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C; Nyberg-Arrhenius V; Wallén P
    Thromb Res; 1981 Mar; 21(6):535-45. PubMed ID: 7022741
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B; Gurewich V; Hyde E
    Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of the activation of Glu-plasminogen by streptokinase and urokinase in the presence of fibrinogen degradation products.
    Takada A; Takada Y
    Thromb Res; 1982 Feb; 25(3):229-35. PubMed ID: 7038978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coagulation on the activation of plasminogen by streptokinase and urokinase.
    Takada A; Urano T; Takada Y
    Thromb Haemost; 1979 Oct; 42(3):901-8. PubMed ID: 505405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin and plasminogen activators: kinetics, and kinetics of plasminogen activation.
    Robbins KC; Wohl RC; Summaria L
    Ann N Y Acad Sci; 1981; 370():588-91. PubMed ID: 6455955
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H; Takada Y; Takada A
    Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of Glu-plasminogen by urokinase in the presence of fibrinogen, fibrin, and SK-potentiator.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):497-501. PubMed ID: 6457416
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies of three different molecular forms of urokinase for the activation of native human plasminogen.
    Toki N; Takasugi S; Sumi H
    Enzyme; 1981; 26(4):221-4. PubMed ID: 6788545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effect of 5,6-trans-prostaglandin E2 on plasminogen activation by urokinase and streptokinase.
    Urano T; Ikeda C; Shimokawa M; Kinoshita T
    Biochim Biophys Acta; 1994 Apr; 1205(2):258-61. PubMed ID: 8155706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasminogen activator and esterase activities of the two forms of urokinase.
    Ong EB; Soberano ME; Johnson AJ; Dharmgrongartama ED
    Thromb Res; 1981 Nov; 24(3):223-32. PubMed ID: 7038974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzymatic fibrinolytic agents].
    Jamet M; Granthil C; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.